Share on LinkedInShare on LinkedIn

ARTICLE · 15 OCTOBER 2020

Arthrex Cert Likely To Spur Previously Discussed Legislative Fix

Ropes & Gray LLP
Ropes & Gray LLP
Contributor
Ropes & Gray LLP

Ropes & Gray LLP

Ropes & Gray is one of the world’s most respected law firms, with offices in key business and...

View firm profile
Explore more from Ropes & Gray LLP

Back in November of 2019 the House Judiciary Committee conducted a hearing entitled "The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions."

United StatesIntellectual Property

Review of APJ Appointments to Be Considered by SCOTUS

Back in November of 2019 the House Judiciary Committee conducted a hearing entitled "The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions." The hearing explored whether or not the Federal Circuit solution pronounced in Arthrex was effective to cure the Appointments Clause defect. While there was some debate over whether the "fix" would hold, all of the witnesses were unanimous in that Congress, could, and should, fix the issue in the short term.

Today, Arthrex was granted cert. I expect that Congress will now turn back to their earlier discussed legislative fix.

First, the questions that will be considered by the SCOTUS:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from